Stay updated on Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe NIH website transition notice about updated terminology and related FAQs was removed from the page. The clinical trial record remains unavailable behind a 403 error.SummaryDifference1%

- Check12 days agoChange DetectedThe site footer now shows revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check19 days agoChange DetectedA sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe error page’s footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision: v3.7.0 was added to the page. A large set of study-related terms, drug names, and the list of participating institutions and investigators was removed, altering how the study is identified and linked to sites.SummaryDifference22%

Stay in the know with updates to Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.